Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 76.43 | N/A |
| PEG Ratio (TTM) | 0.12 | N/A |
| P/S Ratio (TTM) | 1.05 | N/A |
| P/B Ratio (TTM) | 3.45 | N/A |
| P/FCF Ratio (TTM) | 49.59 | N/A |
| Price to 5YR AVG Earnings Ratio | 268.12 | N/A |
| Price to 5YR AVG FCF Ratio | 30.43 | N/A |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.47% | N/A |
| ROE (TTM) | 4.41% | N/A |
| Net Profit Margin (TTM) | 1.41% | N/A |
| ROIC 5YR AVG | 1.35% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -958.50% | -0.36% | -71.13% |
| Revenue | 21.17% | 12.28% | 1.97% |
| Net Income | -1,142.47% | 2.48% | -71.65% |
| Cash Flow | 7.63% | -25.93% | -2,522.02% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.26 | N/A |
| Quick Ratio (TTM) | 0.60 | N/A |
| D/E Ratio (TTM) | 1.02 | N/A |
| Interest Coverage (TTM) | 2.23 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.60 | N/A |
| LTL to 5YR AVG FCF | 0.57 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.72% | N/A |